Triple therapy shown to help with cystic fibrosis in the long term

Cystic fibrosis (CF) is the most common inherited metabolic disease in Europe. More than 8,000 people in Germany are affected. Every year, about 150 to 200 children are born with this incurable disease. It is caused by a defect in the gene for the CFTR transport channel. This disrupts the salt and water balance in the body and leads to thick mucus that can block various organs, including the lungs. The result is repeated infections and inflammation, and lung function gradually deteriorates.